Medicare Enrolled
Dr. Samuel Abourbih, MD,CM
Urology Physician · Middletown, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Abourbih from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Abourbih?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Abourbih
Dr. Samuel Abourbih is an urology physician in Middletown, NY, with 11 years of NPI registration. Based on federal Medicare data, Dr. Abourbih performed 2,122 Medicare services across 1,499 unique beneficiaries.
Between the years covered by Open Payments, Dr. Abourbih received a total of $3,273 from 22 pharmaceutical and/or device companies across 98 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Abourbih is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 11 years in practice
▲ Top 33% volume in NY
$3,273 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,122
Medicare services
Top 33% in NY for urology physician
1,499
Unique beneficiaries
$72
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~193 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
672 | $72 | $180 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
354 | $2 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
218 | $101 | $259 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 125 | $135 | $328 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
98 | $89 | $272 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
87 | $203 | $460 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
69 | $54 | $109 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
56 | $113 | $294 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
55 | $8 | $10 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
54 | $134 | $371 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
44 | $9 | $28 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
44 | $67 | $158 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
43 | $71 | $221 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
41 | $27 | $58 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
30 | $42 | $68 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
25 | $125 | $1,243 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
24 | $21 | $37 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
21 | $50 | $145 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
20 | $112 | $490 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
18 | $27 | $63 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
12 | $285 | $545 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
12 | $41 | $85 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.7% high complexity
6.9% medium
91.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,273
Total received (2018-2024)
Avg $468/year across 7 years
Top 41% in NY for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
22
Companies
98
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,873 (87.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$400 (12.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$455
2023
$746
2022
$410
2021
$612
2020
$209
2019
$618
2018
$223
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PROGENICS PHARMACEUTICALS, INC.
$150
PROCEPT BioRobotics Corporation
$64
Myriad Genetic Laboratories, Inc.
$46
Sumitomo Pharma America, Inc.
$41
Olympus America Inc.
$34
Teleflex LLC
$33
PFIZER INC.
$22
Telix Pharmaceuticals
$22
Hollister Incorporated
$21
ABC Home Medical Supply, Inc.
$21
Top 3 companies account for 57.3% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$512
Verathon Inc.
$400
UroGen Pharma, Inc.
$381
PROCEPT BioRobotics Corporation
$263
PFIZER INC.
$256
Olympus America Inc.
$229
Intuitive Surgical, Inc.
$158
PROGENICS PHARMACEUTICALS, INC.
$150
Sumitomo Pharma America, Inc.
$146
UROVANT SCIENCES INC
$134
Boston Scientific Corporation
$133
Endo Pharmaceuticals Inc.
$127
Hollister Incorporated
$95
Teleflex LLC
$74
Myriad Genetic Laboratories, Inc.
$46
Antares Pharma, Inc.
$44
Bayer Healthcare Pharmaceuticals Inc.
$25
Telix Pharmaceuticals
$22
ABC Home Medical Supply, Inc.
$21
Coloplast Corp
$21
Supernus Pharmaceuticals, Inc.
$19
Janssen Pharmaceuticals, Inc
$16
Top 3 companies account for 39.5% of all-time payments
Associated products mentioned in payments ›
AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · Da Vinci Surgical System · EDEX · ELIQUIS · GEMTESA · GENERAL BPH · GENERAL KIDNEY STONE DISEASE · ILLUCCIX · JELMYTO · MYRBETRIQ · Myrbetriq · NPD Clinical Study · Nubeqa · ORGOVYX · Olympus Laser Devices · Onli · PROLARIS · PYLARIFY · SpeediCath · UROLIFT · VAPRO · VaPro Pocket · XARELTO · XIAFLEX · XTANDI · XYOSTED · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (88%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
20
Per 100K population
5.0
County median income
$96,497
Nearest hospital
GARNET HEALTH MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Abourbih is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Abourbih experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Abourbih performed 672 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Abourbih receive payments from pharmaceutical companies?
Yes. Dr. Abourbih received a total of $3,273 from 22 companies across 98 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Abourbih's costs compare to other urology physicians in Middletown?
Dr. Abourbih's average Medicare payment per service is $72. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Abourbih) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Middletown
Browse urology physicians in Middletown ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NY
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NY
Which NY urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Verathon Inc. Payments to Doctors
See all physicians who received payments from Verathon Inc.
By company
UroGen Pharma, Inc. Payments to Doctors
See all physicians who received payments from UroGen Pharma, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology